
Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
To own Onto Innovation, you need to believe AI-driven advanced packaging, HBM, and next-gen process control will keep needing its tools, even through normal industry swings. The Rigaku stake and recent earnings strength support the near term catalyst around AI infrastructure spending, but they do not remove key risks such as reliance on a rebound in customer demand and exposure to geopolitical tariffs.
The Rigaku announcement feels most relevant here, because it speaks directly to Onto’s AI-oriented metrology roadmap. By pairing X-ray with its optical systems, Onto is trying to deepen its role in CoWoS and HBM inspection, which ties closely to expected Q4 and 2026 AI packaging demand. That same push, however, still sits against customer concentration and the need to keep funding high R&D without clear visibility on order timing.
Yet behind the AI growth story, investors should be aware that concentrated customer exposure and shifting tariffs could still...
Read the full narrative on Onto Innovation (it's free!)
Onto Innovation’s narrative projects $2.0 billion revenue and $539.4 million earnings by 2029.
Uncover how Onto Innovation's forecasts yield a $355.60 fair value, a 16% upside to its current price.
Some of the lowest ranked analysts were already cautious, assuming about US$1.7 billion revenue and US$457 million earnings by 2029, and the latest Rigaku news could either ease or reinforce those concerns about rising costs and market access, so it is worth weighing how far your own expectations differ from theirs.
Explore 7 other fair value estimates on Onto Innovation - why the stock might be worth 37% less than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com